Quantcast

Latest knee osteoarthritis Stories

2014-07-08 10:15:27

University of Oxford Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet today (July 8). A team of researchers from the University of Oxford, funded by Arthritis Research UK and the Royal College of Surgeons, found that: Although the risk of life-threatening complications from knee replacement surgery is very small, people who undergo total knee replacement are four times more likely to die in the first month after...

2014-06-05 13:31:08

American Academy of Orthopaedic Surgeons Knee replacement surgeries far outpace hip replacement surgeries over past 20 years The number of total knee replacement (TKR) surgeries more than tripled between 1993 and 2009, while the number of total hip replacements (THR) doubled during the same time period. A study appearing in the June Journal of Bone and Joint Surgery (JBJS) found that an increase in the prevalence of overweight and obesity in the U.S. accounted for 95 percent of the...

2014-05-14 08:31:36

FREDERICK, Md., May 14, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced more detail on the interim results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. The interim results are now published online at the EULAR (European League against Arthritis) conference website at https://b-com.mci-group.com/AbstractList/EULAR2014.aspx...

2014-05-02 23:05:37

Orthopedic surgeons at La Peer Health Systems’ Knee Surgery Center of Excellence in Los Angeles discuss new evidence that milk helps hold off osteoarthritis of the knee. Beverly Hills, CA (PRWEB) May 02, 2014 According to new research published by the American College of Rheumatology, women who make a habit of consuming low-fat or fat-free milk show a slower progression of knee osteoarthritis. The study also found that women who consume cheese experience faster onset of the disease....

2014-03-30 23:21:50

At Santa Rosa Orthopaedics (SRO), a collaborative team of multi-specialist orthopedic surgeons and experienced physical and occupational therapists work together to bring the best outcomes to patients dealing with chronic knee issues including pain relief, recovery and rehabilitation. Santa Rosa, CA (PRWEB) March 30, 2014 As the largest joint in the body the knee is extremely vulnerable to injury. In fact, more than 10 million people seek out a doctors’ advice every year due to common...

2014-03-14 08:27:35

New study to measure patient outcomes following non-surgical autologous stem cell procedures for treatment of the common degenerative condition DENVER, March 14, 2014 /PRNewswire/ -- Regenerative Sciences, Inc., a company dedicated to advancing orthopedic care through non-surgical adult stem cell procedures, today announced the start of a new clinical research study on the use of autologous stem cells for treating knee osteoarthritis. Photo -...

2014-03-04 23:02:22

The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient characteristics. Mount Laurel, NJ (PRWEB) March 04, 2014 The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient...

2014-02-18 08:31:01

GREENWOOD VILLAGE, Colo., Feb. 18, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has completed enrollment and dosing of 500 patient in the pivotal trial of Ampion((TM)) for the treatment of acute osteoarthritis of-the-knee (OAK). http://clinicaltrials.gov/ct2/show/NCT02024529?term=ampio&rank=1 (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Dr. Vaughan Clift, Ampio's Chief Regulatory Officer, explained: "This phase III,...

2014-02-04 08:28:44

GREENWOOD VILLAGE, Colo., Feb. 4, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ("Ampio" or the "Company") today announced that the article reporting the results of its initial pivotal clinical trial of Ampion(TM) for the treatment of pain due to Osteoarthritis of the knee (OAK), was published in PLOS ONE, an international, rigorously peer-reviewed, open-access, online publication which covers primary research from any discipline within science and medicine, and is...

2014-01-13 08:27:33

GREENWOOD VILLAGE, Colo., Jan.13, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the 500 patient Phase III pivotal trial of Ampion(TM) for the treatment for osteoarthritis of-the-knee (OAK) has received IRB approval and FDA IND clearance and that patients enrollment and treatments have commenced. http://clinicaltrials.gov/ct2/show/NCT02024529?term=ampio&rank=1 (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Dr. Vaughan Clift,...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.